Sino Biopharmaceutical Limited (HKG: 1177)
Hong Kong
· Delayed Price · Currency is HKD 3.310
+0.020 (0.61%)
Nov 15, 2024, 4:08 PM HKT
Sino Biopharmaceutical Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 60,260 | 63,845 | 84,459 | 102,408 | 140,925 | 136,693 | Upgrade
|
| Market Cap Growth | -39.73% | -24.41% | -17.53% | -27.33% | 3.10% | 110.43% | Upgrade
|
| Enterprise Value | 66,464 | 66,382 | 90,167 | 114,126 | 146,103 | 139,402 | Upgrade
|
| Last Close Price | 3.31 | 3.40 | 4.38 | 5.10 | 6.95 | 6.68 | Upgrade
|
| PE Ratio | 26.53 | 24.53 | 31.85 | 5.67 | 39.69 | 40.66 | Upgrade
|
| Forward PE | 17.76 | 17.78 | 20.62 | 12.33 | 33.15 | 34.76 | Upgrade
|
| PS Ratio | 2.05 | 2.21 | 2.87 | 3.11 | 5.02 | 5.04 | Upgrade
|
| PB Ratio | 1.71 | 1.52 | 1.97 | 2.21 | 5.29 | 5.94 | Upgrade
|
| P/TBV Ratio | 1.53 | 1.96 | 2.59 | 2.84 | 7.22 | 8.70 | Upgrade
|
| P/FCF Ratio | 9.75 | 11.60 | 14.88 | 22.84 | 30.42 | 31.53 | Upgrade
|
| P/OCF Ratio | 7.04 | 9.55 | 11.92 | 15.55 | 22.28 | 22.95 | Upgrade
|
| PEG Ratio | 0.97 | 1.33 | - | 0.62 | 3.97 | 2.10 | Upgrade
|
| EV/Sales Ratio | 2.23 | 2.30 | 3.06 | 3.46 | 5.20 | 5.14 | Upgrade
|
| EV/EBITDA Ratio | 9.73 | 9.45 | 12.75 | 17.05 | 21.73 | 19.86 | Upgrade
|
| EV/EBIT Ratio | 11.31 | 11.08 | 14.81 | 20.07 | 30.02 | 25.16 | Upgrade
|
| EV/FCF Ratio | 10.75 | 12.06 | 15.88 | 25.46 | 31.54 | 32.16 | Upgrade
|
| Debt / Equity Ratio | 0.23 | 0.33 | 0.37 | 0.32 | 0.63 | 0.42 | Upgrade
|
| Debt / EBITDA Ratio | 1.43 | 1.97 | 2.22 | 2.21 | 2.48 | 1.36 | Upgrade
|
| Debt / FCF Ratio | 1.68 | 2.54 | 2.81 | 3.36 | 3.64 | 2.22 | Upgrade
|
| Asset Turnover | 0.42 | 0.41 | 0.42 | 0.50 | 0.56 | 0.56 | Upgrade
|
| Inventory Turnover | 2.72 | 2.31 | 2.10 | 2.79 | 2.93 | 3.44 | Upgrade
|
| Quick Ratio | 0.94 | 0.90 | 1.15 | 1.38 | 1.87 | 2.76 | Upgrade
|
| Current Ratio | 1.15 | 1.05 | 1.29 | 1.53 | 2.08 | 3.07 | Upgrade
|
| Return on Equity (ROE) | 12.87% | 12.12% | 11.94% | 55.25% | 20.20% | 16.48% | Upgrade
|
| Return on Assets (ROA) | 5.54% | 5.33% | 5.40% | 5.37% | 6.05% | 7.09% | Upgrade
|
| Return on Capital (ROIC) | 7.35% | 6.60% | 6.60% | 6.69% | 7.78% | 8.83% | Upgrade
|
| Earnings Yield | 8.98% | 4.02% | 3.40% | 17.51% | 2.34% | 2.26% | Upgrade
|
| FCF Yield | 12.62% | 8.62% | 6.72% | 4.38% | 3.29% | 3.17% | Upgrade
|
| Dividend Yield | 1.82% | 1.47% | 2.74% | 1.57% | 1.05% | 0.80% | Upgrade
|
| Payout Ratio | 15.47% | 27.13% | 49.84% | 6.42% | 42.84% | 29.68% | Upgrade
|
| Buyback Yield / Dilution | 2.25% | 2.57% | 1.38% | -2.57% | 0.06% | -1.42% | Upgrade
|
| Total Shareholder Return | 4.08% | 4.04% | 4.12% | -1.00% | 1.11% | -0.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.